| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-07 |